FOLEX Drug Patent Profile
Which patents cover Folex, and when can generic versions of Folex launch?
Folex is a drug marketed by Pharmacia And Upjohn and is included in four NDAs.
The generic ingredient in FOLEX is methotrexate sodium. There is one drug master file entry for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Folex
A generic version of FOLEX was approved as methotrexate sodium by HIKMA on September 16th, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FOLEX?
- What are the global sales for FOLEX?
- What is Average Wholesale Price for FOLEX?
Summary for FOLEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 137 |
| DailyMed Link: | FOLEX at DailyMed |
US Patents and Regulatory Information for FOLEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | FOLEX | methotrexate sodium | INJECTABLE;INJECTION | 087695-001 | Apr 8, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmacia And Upjohn | FOLEX | methotrexate sodium | INJECTABLE;INJECTION | 088954-001 | Oct 24, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmacia And Upjohn | FOLEX | methotrexate sodium | INJECTABLE;INJECTION | 087695-002 | Apr 8, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmacia And Upjohn | FOLEX | methotrexate sodium | INJECTABLE;INJECTION | 087695-003 | Apr 8, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmacia And Upjohn | FOLEX PFS | methotrexate sodium | INJECTABLE;INJECTION | 089180-001 | Jan 3, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
